Answer
The selected product is licensed to reduce cumulative anthracycline-related heart damage in selected adults with advanced or metastatic breast cancer.
Sources for this answer
- CARDIOXANE 500 mg powder for solution for infusionemc · SmPC Current selected SmPC · Version 1